Correlation between an HLA-DQα length polymorphism of messenger RNA and serologically defined specificities (DQwl, DRw53, DR3 + 5)
暂无分享,去创建一个
J. Dausset | D. Cohen | F. Dautry | P. Lehn | V. Lepage | L. Degos | P. Loiseau | J. Colombani
[1] H. Hamaguchi,et al. Identification of the MT3 molecule using two-dimensional gel electrophoresis and alloantisera , 2004, Immunogenetics.
[2] G. Ferrara,et al. The distribution of DR5, MT2, and MB3 specificities on human Ia subsets , 2004, Immunogenetics.
[3] C. Auffray,et al. Molecular genetics of the human major histocompatibility complex. , 1986, Advances in human genetics.
[4] C. Auffray,et al. Exuberant restriction fragment length polymorphism associated with the DQ alpha-chain gene and the DX alpha-chain gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[5] H. Cann,et al. DNA Polymorphism of HLA Class I and Class II Regions , 1985, Immunological reviews.
[6] M. Krangel. Unusual RNA splicing generates a secreted form of HLA‐A2 in a mutagenized B lymphoblastoid cell line. , 1985, The EMBO journal.
[7] K. Horibe,et al. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines. , 1984, Journal of immunology.
[8] J. Dausset,et al. Clusters of HLA class II beta restriction fragments describe allelic series. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Spielman,et al. Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Strominger,et al. Characterization of a B lymphoblastoid cell line mutant that secretes HLA-A2. , 1984, Journal of Immunology.
[11] D. Larhammar,et al. Both alpha and beta chains of HLA‐DC class II histocompatibility antigens display extensive polymorphism in their amino‐terminal domains. , 1984, The EMBO journal.
[12] C. Auffray,et al. Isotypic and allotypic variation of human class II histocompatibility antigen alpha-chain genes. , 1984, Nature.
[13] G. Ferrara,et al. Serologically detectable polymorphism of the HLA-DC alpha-subunit. , 1984, Journal of Immunology.
[14] C. Auffray,et al. Isotypic and allotypic variation of human class II histocompatibility antigen α-chain genes , 1984, Nature.
[15] J. Silver,et al. Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Bodmer,et al. Sequences related to HLA-DR alpha chain on human chromosome 6: restriction enzyme polymorphism detected with DC alpha chain probes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Karr,et al. Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis , 1982, The Journal of experimental medicine.
[18] D. Larhammar,et al. Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Karr,et al. Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. , 1982, Journal of immunology.
[20] J. Strominger,et al. Demonstration of structural polymorphism among HLA-DR light chains by two-dimensional gel electrophoresis , 1980, The Journal of experimental medicine.
[21] R. Duquesnoy,et al. Identification of an HLA-DR-associated system of B-cell alloantigens. , 1979, Transplantation proceedings.
[22] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[23] G. Ferrara,et al. Immunological dissection of human Ia molecules , 1978, The Journal of experimental medicine.